<DOC>
	<DOC>NCT01030640</DOC>
	<brief_summary>Subcutaneous administration of tanezumab can result in changes in the number of nerves around the injection site in the thigh.</brief_summary>
	<brief_title>Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis, Interstitial</mesh_term>
	<criteria>Healthy subjects only Female subjects can not be pregnant or be nursing. Females and males need to use two types of birth control methods during the length of the study and one of the two methods needs to be a barrier method. Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. Subject can not have any chronic or acute medical condition or have had any chronic illness in the past Can not have any problematic skin condition. Females can not have more than 7 alcoholic drinks per week and males can not have more than 14 alcoholic drinks per week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>intraepidermal nerve fiber density</keyword>
	<keyword>IENF</keyword>
	<keyword>tanezumab</keyword>
	<keyword>subcutaneous</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>